Literature DB >> 8019793

Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives.

O Martínez-González1, J Cantero-Hinojosa, P Paule-Sastre, J C Gómez-Magán, D Salvatierra-Ríos.   

Abstract

Patients with AS were previously found to have increased intestinal permeability using the 51Cr-EDTA resorption test. In order to discover whether this alteration has taken place prior to, or as a consequence of the disease, we studied the intestinal permeability to 51Cr-EDTA in 20 patients with AS, 65 of their healthy relatives, and 25 normal volunteers. We also considered the HLA B27 antigen, the serum immunoglobulin A levels, the disease activity, the existence of peripheral arthritis, the ESR, the CRP values and the intake of drugs at the time of study. Gut permeability was found to have increased in the patients and their healthy relatives compared to the control group. No difference in gut permeability was found between patients and relatives regardless of whether they had the HLA B27 antigen or not. The increased intestinal permeability in the patients had no relation to the disease activity, to the presence of peripheral arthritis or to the intake of NSAIDs. Gut permeability was shown to bear no relation to IgA levels, ESR or CRP. Our findings suggest that the increase in gut permeability in AS patients and their relatives is a primary defect and may be an aetiologic factor in this disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019793     DOI: 10.1093/rheumatology/33.7.644

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  33 in total

Review 1.  The intestinal microbiome in spondyloarthritis.

Authors:  Tejpal Gill; Mark Asquith; James T Rosenbaum; Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

Review 2.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

Review 3.  Does the microbiome play a causal role in spondyloarthritis?

Authors:  James T Rosenbaum; Phoebe Lin; Mark Asquith; Mary-Ellen Costello; Tony J Kenna; Matthew A Brown
Journal:  Clin Rheumatol       Date:  2014-05-10       Impact factor: 2.980

Review 4.  Leaky gut and autoimmune diseases.

Authors:  Alessio Fasano
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

5.  A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study.

Authors:  Lars E Bartels; Alma B Pedersen; Nickolaj R Kristensen; Hendrik Vilstrup; Kristian Stengaard-Pedersen; Jens F Dahlerup
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 6.  Intestinal permeability defects: is it time to treat?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

Review 7.  Update on ankylosing spondylitis: current concepts in pathogenesis.

Authors:  Judith A Smith
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

Review 8.  The role of the microbiome in rheumatic diseases.

Authors:  Nigel Yeoh; Jeremy P Burton; Praema Suppiah; Gregor Reid; Simon Stebbings
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

Review 9.  The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?

Authors:  Matthew L Stoll; Randy Q Cron
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 10.  Does the Microbiome Cause B27-related Acute Anterior Uveitis?

Authors:  James T Rosenbaum; Phoebe Lin; Mark Asquith
Journal:  Ocul Immunol Inflamm       Date:  2016-03-22       Impact factor: 3.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.